Ironwood Pharmaceuticals (IRWD) Enterprise Value (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Enterprise Value across 17 years of filings, most recently posting $616.5 million for Q2 2026.

• In Q2 2026, Enterprise Value rose 2458.17% year-over-year to $616.5 million; the TTM figure through Jun 2026 stood at $616.5 million (up 2458.17% YoY), while the FY2025 annual figure was $334.1 million, down 46.22% from the prior year.
• Enterprise Value came in at $616.5 million for Q2 2026 at Ironwood Pharmaceuticals, up from $357.3 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $1.7 billion in Q4 2023 to a low of $24.1 million in Q2 2025.
• Average Enterprise Value over 5 years is $848.2 million, with a median of $914.3 million recorded in 2023.
• Year-over-year, Enterprise Value plunged 97.43% in 2025 and soared 2458.17% in 2026.
• Over 5 years, Enterprise Value stood at $1.3 billion in 2022, then soared by 35.63% to $1.7 billion in 2023, then sank by 63.39% to $621.2 million in 2024, then sank by 46.22% to $334.1 million in 2025, then surged by 84.56% to $616.5 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $616.5 million in Q2 2026, $357.3 million in Q1 2026, and $334.1 million in Q4 2025.